Clinical Trial Update: A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects [Phase 3]

View source ↗

Summary

Phase III trial to evaluate the efficacy and safety of GZR18 Injection in adults who are obese or overweight; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• GZR18 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Obesity/Overweight | Phase 3 | Status: ACTIVE_NOT_RECRUITING